Advertisement

The phosphatidylinositol 3-kinase-δ inhibitor CAL-101 demonstrates promising pre-clinical activity in chronic lymphocytic leukemia by antagonizing intrinsic and extrinsic cellular survival signals

Sarah E. M. Herman, Amber L. Gordon, Amy J. Wagner, Nyla A. Heerema, Weiqiang Zhao, Joseph M. Flynn, Jeffrey Jones, Leslie Andritsos, Kamal D. Puri, Brian J. Lannutti, Neill A. Giese, Xiaoli Zhang, Lai Wei, John C. Byrd and Amy J. Johnson

Article Information

PubMed 

Print ISSN 
Online ISSN 
History 
  • Submitted February 25, 2010
  • Accepted May 24, 2010
  • Published online June 3, 2010.

Article Versions


Contributors 
  • Sarah E. M. Herman
  • Amber L. Gordon
  • Amy J. Wagner
  • Nyla A. Heerema
  • Weiqiang Zhao
  • Joseph M. Flynn
  • Jeffrey Jones
  • Leslie Andritsos
  • Kamal D. Puri
  • Brian J. Lannutti
  • Neill A. Giese
  • Xiaoli Zhang
  • Lai Wei
  • John C. Byrd
  • Amy J. Johnson

Altmetric.com Statistics

The Altmetric score is a weighted count of online attention designed to reflect the volume and reach of online engagement surrounding an individual research output